ProCE Banner Activity

The How: Current Predictors of Response to Immune Checkpoint Inhibitors

Slideset Download
Download this slideset to review expert guidance on optimal biomarker testing in lung cancer, including molecular testing by NGS and PD-L1 testing to predict response to checkpoint inhibitor–based therapy.

Released: November 05, 2019

Expiration: November 03, 2020

Share

Faculty

Sanjay Mukhopadhyay

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bristol Myers Squibb

Genentech TEXT Only

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio